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OBJECTIVES We evaluated the effectiveness of contrast-enhanced cardiac magnetic resonance (CE-CMR)
in detecting chronic myocarditis (CM).
BACKGROUND Chronic myocarditis represents a common evolution of acute myocarditis. Although
CE-CMR has been revealed to be effective in identifying areas of myocardial damage in acute
myocarditis, its role in the diagnosis of chronic myocardial inflammation has not yet been
investigated.
METHODS Twenty-three patients with CM underwent CE-CMR and endomyocardial biopsy (EMB).
Chronic myocarditis was defined by the presence of: 1) chronic (6 months) heart failure
symptoms and/or repetitive ventricular arrhythmias; 2) no history of recent flu-like symptoms
or infections; and 3) histologic evidence of active myocarditis (AM) or borderline myocarditis
(BM) according to Dallas criteria. Contrast-enhanced cardiac magnetic resonance included
black-blood T2-weighted (BBT2w) images without and with fat saturation and delayed
three-dimensional T1 turbo field-echo inversion-recovery sequences obtained 15 min after
gadolinium injection.
RESULTS Histology showed AM in 14 patients and BM in 9 patients. FatSat BBT2w revealed the
presence of edema in five (36%) patients with AM but not in BM patients. Areas of late
enhancement (LE) were observed in 12 (84%) subjects with AM and in 4 (44%) cases with
BM. A mid-wall LE pattern was the most frequent finding in both groups while a
subepicardial distribution of LE was observed only in patients with AM.
CONCLUSIONS Contrast-enhanced cardiac magnetic resonance identified areas of myocardial inflammation
in up to 70% of patients with biopsy-proven CM. We suggest that CE-CMR may be a useful
non-invasive diagnostic tool in patients with CM, and it may indicate and even guide the
execution of left ventricular EMB with relevant prognostic and therapeutic implications. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.067Coll Cardiol 2006;47:1649–54) © 2006 by the American College of Cardiology Foundation
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Clinical manifestations of myocarditis are extremely various,
anging from asymptomatic state to fulminant acute heart
ailure, conduction disturbances, or ventricular tachyarrhyth-
ias (1,2), and even global biventricular dysfunction in patients
ith coronary artery disease (3).
A spontaneous recovery may occur in the acute phase in
p to 50% of patients (4), but chronic inflammatory cardio-
yopathy and dilated cardiomyopathy sustained by both
iral persistence and autoimmune self-perpetration represent a
ommon evolution of the disease (5–7). The diagnosis of
yocarditis has relevant therapeutic implications as immuno-
uppressive therapy and interferon-beta administration has
een revealed effective in autoimmune and viral myocarditis,
espectively (6,7). Unfortunately, laboratory tests, serologic
tudies, and non-invasive tools are unable to provide a
From the *Radiology Department, †Cardio-Thoracic and Vascular Department,
nd ‡Internal Medicine Department, San Raffaele Scientific Institute and Università
ita-Salute San Raffaele, Milan, Italy; and the §Department of Heart and Great
essels “Attilio Reale,” La Sapienza University Rome, Rome, Italy.m
Manuscript received July 5, 2005; revised manuscript received October 19, 2005,
ccepted November 28, 2005.efinite diagnosis of myocarditis that still relies on endo-
yocardial biopsy (EMB) (5–7). Cardiac magnetic reso-
ance (CMR) imaging with gadolinium late enhancement
LE) may identify areas of myocardial damage in myocardial
nfarction (8), hypertrophic and dilated cardiomyopathies
9,10). Recent studies (11,12) have demonstrated that
ontrast-enhanced cardiac magnetic resonance (CE-CMR)
ay be useful in non-invasive recognition of myocardial
nflammation in patients with acute myocarditis (AM).
owever, the sensitivity of CE-CMR in detecting myocar-
ial inflammation in patients without clinical evidence of
M remains unknown.
In the present study we sought to investigate whether
E-CMR may allow the non-invasive recognition of myocar-
ial inflammation in patients with chronic myocarditis (CM).
ETHODS
atient population. Twenty-three consecutive patients with
M were submitted to CE-CMR before EMB. Chronic
yocarditis was defined by the presence of the following
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CMR in Chronic Myocarditis April 18, 2006:1649–54riteria: 1) chronic (6 months) heart failure symptoms
nd/or repetitive ventricular arrhythmias (Lown class III to
Va) with or without left ventricular (LV) systolic dysfunc-
ion; 2) no history of recent flu-like syndrome or gastroin-
estinal or upper respiratory infection; 3) evidence of AM or
orderline myocarditis (BM) according to Dallas criteria
13) on EMB. Patient population included 8 women and 15
en. Clinical presentation was represented by symptoms of
eart failure in 9 patients and repetitive ventricular arrhyth-
ias in 14 patients. These 14 patients presented persisting
entricular ectopic beats at three consecutive electrocardio-
raphic Holter monitoring executed monthly. No patient
xperienced sustained ventricular tachycardia requiring di-
ect current shock or implantable cardioverter defibrillator
mplantation. No patient showed pericardial effusion nor
roponin I elevation.
MR imaging acquisition and analysis. Cardiac magnetic
esonance was performed before cardiac catheterization on a
.5-T whole-body scanner (Gyroscan Intera Master; Philips
edical Systems, Best, the Netherlands) by using an enhanced
radient system (maximum gradient strength: 30 mT/m;
aximum gradient slew rate: 150 mT·m1·s1) and a
ve-element cardiac phased-array coil (SENSE Cardiac,
hilips Medical Systems, Bothell, Washington).
Morphologic images in the cardiac short-axis, four-
hamber long-axis, and two-chamber long-axis planes
ere acquired by using black-blood T2-weighted
BBT2w) sequences without and with fat suppression;
BT2w images with fat suppression were visually evalu-
ted to detect areas of hyperintensity suggesting the pres-
nce of edema.
In the same planes cine-magnetic resonance imaging was
erformed by using a breath-hold steady-state free preces-
ion (SSFP) sequence with parallel imaging (SENSE, Phil-
ps Medical Systems, Best, the Netherlands) as previously
escribed (14).
Left ventricle end-diastolic and -systolic volumes, stroke
olume, ejection fraction (EF) cardiac output, and myocar-
ial mass were calculated from a stack of sequential short-
xis cine loops (8 to 12 contiguous slices) by semi-automatic
Abbreviations and Acronyms
AM  active myocarditis
BBT2w  black-blood T2-weighted
BM  borderline myocarditis
CE-CMR  contrast-enhanced cardiac magnetic
resonance
CM  chronic myocarditis
CMR  cardiac magnetic resonance
EF  ejection fraction
EMB  endomyocardial biopsy
LE  late enhancement
LV  left ventricle/ventricular
PCR  polymerase chain reaction
RV  right ventricle/ventricularegmentation (EasyVision; Philips Medical Systems) of endo- pardial and epicardial borders on each frame as previously
escribed (14).
The LE short- and long-axis images were acquired 10 to
5 min after peripheral bolus injection of gadolinium-
TPA (Shering AG, Berlin, Germany) (0.2 mmol/kg of
ody weight) by using a three-dimensional TFE-inversion-
ecovery T1-weighted sequence (repetition time: 3.8 to 4.1
s; echo time: 1.2 ms; flip angle: 15°, inversion time: 200 to
00 individually optimized to null myocardial signal, matrix:
56; thickness: 5 mm).
The extension of LE was planimetered by an experienced
perator on 20 contiguous short-axis images, summed up to a
olume and expressed as a percentage of total myocardium.
The location and the pattern (subendocardial, mid-wall,
ubepicardial, or transmural) of LE were assessed by the
onsensus of two expert observers unaware of the patholog-
cal findings.
ardiac catheterization and EMB. All patients were sub-
itted to cardiac catheterization, coronary angiography, LV
nd right ventricular (RV) angiography with end-diastolic
ressure measurements and biventricular EMB. Endo-
yocardial biopsies (three to four from each ventricle)
ere performed in the septal-apical region; two to three
amples were immediately frozen in liquid nitrogen for
olecular studies. The remaining tissue specimens were
xed in 10% buffered formalin and embedded in paraffin
ax. All invasive cardiac procedures were performed after
nformed patient consent and approval by the ethics
ommittees of our institutions.
istology and immunohistochemistry. Four to six sam-
les from each patient were processed for histology and
mmunohistochemistry. All samples from the same patient
ere analyzed together. The diagnosis of myocarditis was
ade according to Dallas criteria (13) and by immunohis-
ochemical characterization of inflammatory infiltrates (6).
he presence of inflammatory infiltrates with foci of necro-
is of adjacent myocytes in at least one specimen was
iagnostic for AM. Morphometric quantification of fibrosis
as performed on Masson’s trichrome sections using an
utomated system (Nikon, Japan).
olecular biology studies. Two frozen myocardial speci-
ens from each patient were used for polymerase chain
eaction (PCR) and reverse transcriptase PCR analysis. Ten
rimer pairs were used to detect cardiotropic viruses’ de-
xyribonucleic and ribonucleic acid. The purified PCR
roducts were sequenced directly on an automated ABI
Foster City, California) model 310 A sequencer, as previ-
usly described (2,6).
ESULTS
ardiac catheterization and EMB findings. All patients
resented normal epicardial coronary arteries and increased
V end-diastolic pressure (19.3  3.6 mm Hg, range 14 to
5 mm Hg). Histology showed the presence of AM in 14
atients: inflammatory infiltrates were present in both LV
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April 18, 2006:1649–54 CMR in Chronic Myocarditisnd RV myocardial samples in 5 patients, only in LV
amples in 8 cases, and only in RV samples in 1 case. The
emaining nine patients showed histological evidence of
M: inflammatory infiltrates were present in both LV and
V myocardial samples in three cases, confined to LV samples
n five patients, and to RV samples in one case. At immuno-
istochemistry, inflammatory infiltrates were mainly repre-
ented by activated T-lymphocytes (CD 45RO) in all pa-
ients. Morphometric studies showed that in BM patients
nterstitial and replacement fibrosis extent was significantly
igher than in AM patients (18 5% vs. 7 2%, p 0.05).
OLECULAR BIOLOGY STUDIES. Polymerase chain reaction
n frozen myocardial samples detected the presence of viral
enome in five patients with AM and in four patients with
M (Table 1).
MR results. Systolic function (EF 50%) was depressed
n the 9 patients with heart failure symptoms and normal
EF 50%) in the remaining 14 patients (Table 1).
FatSat BBT2w image analysis revealed the presence of
reas of hyperintensity in the myocardium in only 5 of 23
atients (22%), all presenting AM.
Contrast-enhanced CMR analysis showed LE in 16 of 23
atients (70%) (Figs. 1 and 2). A mid-wall distribution was
bserved in 10 patients (62.5%), and a subepicardial distri-
ution was observed in 6 cases (37.5%). There was no
orrelation between the presence/absence of LE or its extent
mean  SD, 7.3  6.4%, range 0% to 19%) and any
unctional or hemodynamic parameters.
able 1. Clinical, Histological, and CMR Features of Patient Po
Patient Gender Age (yrs) EF (%)
Clinical
Presentatio
1 M 30 64.2 VA
2 F 31 21.1 HF
3 F 29 66.6 VA
4 M 70 58.0 VA
5 M 44 58.0 VA
6 F 50 69.8 VA
7 M 37 59.8 VA
8 F 18 47.2 HF
9 M 37 48.6 HF
10 F 37 55.5 VA
11 F 48 78.8 VA
12 M 59 47.4 HF
13 M 63 58.8 VA
14 M 37 45.1 HF
15 M 56 55.5 VA
16 M 58 28.8 HF
17 M 26 51.5 VA
18 F 31 57.6 VA
19 M 36 29.4 HF
20 M 52 40.2 HF
21 M 19 57.1 VA
22 F 25 43.9 HF
23 M 41 61.0 VA
M  active myocarditis; AV  adenovirus; BM  borderline myocarditis; CMR 
nterovirus; HF heart failure; LE late enhancement; LV left ventricle; MSmid-wa
triae; VA  ventricular arrhythmias.omparison of contrast-enhancement versus EMB find-
ngs. AM GROUP. Areas of LE were observed in 12 of 14
atients with a sensitivity of CE-CMR in detecting AM of
6%. In particular, LE was present in 12 of 13 patients with
vidence of LV or biventricular myocarditis (92%) (Fig. 3),
ut was absent in the remaining patient with isolated RV
nvolvement. In six cases LE showed a mid-wall and in six
subepicardial distribution with the mid-posterior and
id-lateral LV walls being the most frequently involved
egments. Patients with LE subepicardial distribution pre-
ented heart failure symptoms in three cases and repetitive
entricular arrhythmias in the other three. In six patients
ith evidence of mid-wall LE, two subjects had symptoms
f heart failure and four had an arrhythmic presentation.
M GROUP. Areas of LE were present only in four cases
44%), always with a mid-wall pattern (Fig. 3); in these
atients clinical presentation was represented by ventricular
rrhythmias in three cases and heart failure in one. Histo-
ogical analysis showed in all cases inflammatory infiltrates
ssociated with extensive areas of replacement fibrosis sug-
esting a healing phase of the inflammatory process.
ISCUSSION
yocardial inflammation represents a potentially treatable
ause of chronic cardiac symptoms, but its non-invasive
dentification is still difficult. In the present study we show
hat CE-CMR may detect LE areas in up to 70% of
atients with biopsy-proven CM presenting with heart
ion
Histology PCR
Affected
Ventricle
LE
Pattern LE (%)
AM AV RV — —
BM EBV LV, RV MS 12
AM LV SS 11
AM AV LV MS 4
AM LV, RV SS 4
AM EV LV, RV MS 3
BM LV, RV — —
AM LV, RV MS 17
AM AV LV, RV SS 10
BM EBV LV MS 11
BM AV LV — —
AM LV — —
AM EV LV, RV MS 11
BM LV — —
BM EBV LV, RV MS 14
AM LV SS 9
BM LV — —
AM LV SS 17
BM RV — —
AM LV MS 13
BM LV MS 19
AM LV SS 7
AM LV MS 6
iac magnetic resonance; EBV  Epstein-Barr virus; EF  ejection fraction; EV pulat
n
card
ll striae; PCR polymerase chain reaction; RV right ventricle; SS subepicardial
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CMR in Chronic Myocarditis April 18, 2006:1649–54ailure or ventricular arrhythmias. These findings were ob-
erved in patients submitted to biventricular EMB with exten-
ive sampling and immunohistochemical and molecular biol-
gy studies increasing the diagnostic sensitivity of the
rocedure. In particular, LE was observed in 86% of patients
ith histologic evidence of AM and in 44% of patients with
M. The percentage of patients with AM presenting LE of
he LV increases to 92% when excluding one patient with
M confined to the RV. These findings are consistent with
he recently reported sensitivity of the CMR in detecting
M (11,15).
The high percentage of patients with positive LE find-
ngs in the AM group compared with patients with BM
uggest that LE is mainly related to myocardial necrosis and
dema characterizing the active phase of the inflammatory
rocess and representative of an ongoing myocardial inflam-
ation. Conversely, the extensive areas of replacement
brosis observed at histology appear to be the most likely
ubstrate of LE in patients with BM.
The presence of a different LE substrate in the two
igure 1. Patient with active myocarditis. Contrast-enhanced cardiac
agnetic resonance short-axis imaging (A) shows a subepicardial late-
nhancement stria in the posteroinferior left ventricular wall (arrows). (B)
eft ventricular endomyocardial biopsy shows clusters of lymphocytic
nflammatory infiltrates associated with necrosis of adjacent myocytes
hematoxylin and eosin, original magnification 400).roups is also suggested by the different LE pattern ob- aerved in our series. In fact, although a mid-wall pattern was
he most frequent finding in both groups, a subepicardial
istribution of LE was observed only in patients with AM,
hile all BM patients showed a mid-wall pattern, com-
only observed in dilated cardiomyopathy as reported by
cCrohon et al. (10). With regard to this, the evidence of
igure 2. Patient with borderline myocarditis. (A) In the TFE-inversion
ecovery T1-weighted long-axis four-chamber view, a mesocardial late-
nhancement stria in the lateral medio-basal wall and small late-
nhancement foci in interventricular septum are present. Long-axis two-
hamber image (B) shows a mid-wall late-enhancement stria in the inferior
edio-basal left ventricular wall. Left ventricular endomyocardial biopsy
C) showing sparse inflammatory infiltrates without myocyte necrosis
ndicating a borderline myocarditis (hematoxylin and eosin, original mag-
ification 250).similar LE pattern suggests that an underlying chronic
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April 18, 2006:1649–54 CMR in Chronic MyocarditisM may be present in some patients with non-invasive
iagnosis of dilated cardiomyopathy; the distinction be-
ween these two entities, detectable through EMB, is
elevant as effective therapeutic strategies may be adopted in
he presence of chronic myocardial inflammation and/or
igure 3. Different patterns of late enhancement. (A) TFE-inversion
ecovery T1-weighted images shows late-enhancement stria in right
entricular free wall (arrow) in a patient with active myocarditis involving
oth ventricles. (B) Contrast-enhanced cardiac magnetic resonance show-
ng late-enhancement foci in the lateral wall in active myocarditis. (C)
FE-inversion recovery T1-weighted images showing a mid-wall late-
nhancement stria located in the medial interventricular septum in a
atient with heart failure and borderline myocarditis.iral infection (6,7).In contrast with the recently reported high sensitivity of
2-weighted sequence in diagnosing AM (12), in our study,
sing a similar technique, FatSat BBT2w images revealed
he presence of hyperintensity only in 22% of patients, all
ith AM. These findings reflect the different underlying
athologic substrate of CM characterized by myocardial
dema mostly in the presence of consistent areas of cell
ecrosis. Therefore, considering the low sensitivity of T2-
mages observed in our series, this part of CMR evaluation
ppears to be ancillary in the diagnostic evaluation of
atients with CM.
Our findings have relevant clinical implications as the
ecognition of myocarditis may be easy in the acute phase
hen myocardial inflammation is often accompanied by
ever, troponin, and inflammatory marker elevation in pe-
ipheral blood, but it is more difficult when the process
ecomes chronic because of viral persistence or autoimmune
volution. In these settings, the execution of CE-CMR may
epresent a useful non-invasive tool in indicating and even
uiding the execution of EMB.
In fact, the diagnosis of CM, mostly when accompanied by
ssessment of myocardial presence of viral genome and evalu-
tion of autoimmune activation, may have relevant prognostic
nd therapeutic implications as a selective treatment with
mmunosuppression (6), immunoadsorption (16), high-dose
mmunoglobulin (17), or beta-interferon (7), which may pro-
ide recovery of cardiac function.
In conclusion, CE-CMR in patients with chronic cardiac
ymptoms in the absence of coronary artery disease may
on-invasively identify areas of myocardial damage suggest-
ng the presence of a myocardial inflammatory process.
eprint requests and correspondence: Dr. Francesco De Cobelli,
epartment of Radiology, Vita-Salute University/San Raffaele
cientific Institute, Via Olgettina 60, Milano 20132, Italy. E-mail:
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